Home › NDC Lookup › Ingredients › Lidocaine5% Phenylephrine Hcl 0.25% Hemo... › 85248-0018-01
Dr.Seymour Butts Hemorrhoid Lidocaine5% Phenylephrine HCl 0.25% 5 g/100g; .25 g/100g Ointment, 30 g — NDC 85248-0018-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Dr.Seymour Butts Hemorrhoid Lidocaine5% Phenylephrine HCl 0.25% 5 g/100g; .25 g/100g Ointment, 30 g — NDC 85248-018-01 (Billing 85248-0018-01)

by Jiangxi Yudexi Pharmaceutical Co., LTD · 30 g in 1 TUBE

This is a package of 30 g of Dr.Seymour Butts Hemorrhoid Lidocaine5% Phenylephrine HCl 0.25% 5 g/100g; .25 g/100g Ointment from Jiangxi Yudexi Pharmaceutical Co., LTD, marketed since Jan 2026 and currently FDA-listed. It is this product's only package size.

NDC 85248-0018-01
🏷️ FDA NDC (as labeled) 85248-018-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 85248-018-01
Product NDC 85248-018
11-digit billing NDC 85248001801
RxCUI 2672354
UNII 98PI200987, 04JA59TNSJ
Application # M015
SPL Set ID 4981c7d9-53ee-2a7b-e063-6394a90add01
Established class (EPC) Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Local Anesthesia
Chemical class Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-01-29
Route TOPICAL
Dosage form OINTMENT
Substance LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE
Quick answers
  • RxCUI (RxNorm): 2672354
Why two NDCs? The FDA registers this code as 85248-018-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 85248-0018-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Antiarrhythmic class.

Pharmacologic class Antiarrhythmic, Amide Local Anesthetic
Drug family (ATC) Antiarrhythmics, class Ib, Local anesthetics, Anesthetics for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

This is a topical ointment for external hemorrhoid symptom relief marketed under FDA over-the-counter monograph rules. It contains lidocaine, a local anesthetic typically used to numb pain and itching, and phenylephrine hydrochloride, a decongestant commonly used to reduce swelling and shrink blood vessels. The product is applied directly to the affected area as an ointment.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
85248-0018-01 You're viewing this Main listing 30 g in 1 TUBE 2026-01-29 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Verdibliss HEMORRHOID RELIEF OINTMENTS .0025 g/g; .05 g/g 76986-0034-01 Guangdong 42.5 g — — FDA listed —
Dr.Seymour Butts Hemorrhoid 5 g/100g; .25 g/100gthis 85248-0018-01 Jiangxi 30 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Jan 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII H4N855PNZ1
    Alpha-tocopherol is a form of vitamin E, a fat-soluble antioxidant derived from natural or synthetic sources. In medicines, it prevents oils and fats from breaking down and becoming rancid, protecting the product's stability and shelf life.
  • UNII 9E8X80D2L0
    A synthetic form of vitamin E used as an antioxidant and preservative in medications. It helps prevent the active ingredients from degrading when exposed to oxygen or light.
  • UNII ZY81Z83H0X
    Aloe vera leaf is a plant extract derived from the aloe plant. It is used in medicines as a natural moisturizer and skin-soothing agent in topical formulations.
  • UNII 104HF4767P
    Baptisia alba is a plant extract used in some formulations as a natural flavoring or coloring agent. It may also function as a botanical filler to add bulk to the medicine.
  • UNII 4PW41QCO2M
    Indian frankincense is a natural resin extracted from trees native to India. It is used in medicines as a binder and thickening agent to help hold ingredients together and improve texture.
  • UNII 3U3U118F2L
    A plant extract from calendula flowers used as a natural colorant and flavoring agent in medicines. It may add color or mild taste to the product.
  • UNII C9H2L21V7U
    A fat derived from coconut or palm oil containing shorter fatty acid chains. It serves as a solvent and carrier to help dissolve or suspend active ingredients, improving absorption and stability in liquid formulations.
  • UNII 4YS74Q4G4J
    A plant extract from Centella asiatica containing natural compounds called triterpenoids. It's used as an active ingredient in some formulations for its purported skin-supporting properties, though it functions as a botanical additive rather than a structural component of the medicine.
  • UNII 2DMT128M1S
    A waxy solid derived from plant or animal sources. It acts as an emulsifier to blend oil and water components, and also thickens the medicine to give it the right texture and consistency.
  • UNII 147D247K3P
    Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
  • UNII 230OU9XXE4
    A waxy substance made from glycerin and stearic acid that acts as an emulsifier to blend oily and watery ingredients together. It also helps thicken and stabilize the medicine's texture.
  • UNII YD01N1999R
    A waxy substance made from polyethylene glycol and stearic acid. It helps mix oil and water-based ingredients together and serves as an emulsifier and solubilizer in liquid and semi-solid medicines.
  • UNII 4T6H12BN9U
    Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII K49155WL9Y
    Shea butter is a fat extracted from shea tree nuts. It's used in medicines as an emollient and lubricant to soften the product, improve texture, and help ingredients blend smoothly together.
  • UNII 01X0P6GX6C
    A plant extract from Swertia japonica used in herbal and traditional medicine formulations. It may serve as an active botanical ingredient or functional component rather than a typical inactive filler or binder.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII 101I4J0U34
    Witch hazel is a plant extract obtained from the leaves and bark of the North American shrub Hamamelis virginiana. It functions as an astringent and skin-conditioning agent in topical products, helping to tone and prepare the skin.

18 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesPurified Water，Witch Hazel Extract, Aloe Vera Extract, Boswellia serrata Extract, Sophora， japonica Extract, Calendula Extract, Centella asiatica Extract, Vitamin E (Tocopherol), Tocopheryl Acetate, Petrolatum USP, Shea Butter, Glycerin, Caprylic/Capric Triglycerides (MCT), Cetearyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Phenoxyethanol, Ethylhexylglycerin.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerJiangxi Yudexi Pharmaceutical Co., LTD
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code85248
First marketedJan 2026
Product typeHuman Otc Drug
Portfolio214 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 16 words ▾

Use Temporarily shrinks hemorrhoidal tissue and relieves pain, soreness, burning, itching, and discomfort associated with hemorrhoids.

⏱️ Dosage and Administration 71 words ▾

Directions Adults: When practical, cleanse the affected area with mild soap and warm water, rinse thoroughly, and gently dry. Apply to the affected area up to 4 times daily, especially at night, in the morning, and after each bowel movement. To use applicator: lubricate applicator; gently insert partway into the anal canal and apply a small amount. Clean applicator after each use. Children under 12 years of age: ask a doctor.

⚠️ Warnings 23 words ▾

Warnings For external use only Allergy alert: do not use if you have a history of allergy to amide-type local anesthetics (e.g., lidocaine).

📦 Storage and Handling 6 words ▾

Other information Store at 20–25°C (68–77°F).

🧪 Active Ingredient 7 words ▾

Active Ingredient Lidocaine 5% Phenylephrine HCl 0.25%

🧪 Inactive Ingredients 41 words ▾

Inactive ingredients Purified Water，Witch Hazel Extract, Aloe Vera Extract, Boswellia serrata Extract, Sophora， japonica Extract, Calendula Extract, Centella asiatica Extract, Vitamin E (Tocopherol), Tocopheryl Acetate, Petrolatum USP, Shea Butter, Glycerin, Caprylic/Capric Triglycerides (MCT), Cetearyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Phenoxyethanol, Ethylhexylglycerin.

🎯 Purpose 3 words ▾

Purpose Local anesthetic，Vasoconstrictor

📄 Do Not Use 36 words ▾

Do not use • if the tube seal is broken or missing • in children under 12 years of age unless directed by a doctor • for more than 7 days unless directed by a doctor

📄 Ask a Doctor Before Use If 26 words ▾

Ask Doctor • heart disease, high blood pressure, thyroid disease, or diabetes • difficulty urinating due to an enlarged prostate • allergies to amide-type local anesthetics

📄 When Using This Product 47 words ▾

When Using • avoid contact with eyes • do not exceed the recommended dosage unless directed by a doctor • do not put this product into the rectum (use the applicator as directed) • if introduction of applicator causes additional pain, stop use and ask a docto

📄 Stop Use and Ask a Doctor If 33 words ▾

Stop Use • bleeding occurs • condition worsens or does not improve within 7 days • redness, irritation, swelling, pain, or rash develops If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep Oot Of Reach Of Children If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 4 words ▾

PRINCIPAL DISPLAY PANEL 5

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Jiangxi Yudexi Pharmaceutical Co., LTD. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Jiangxi Yudexi Pharmaceutical Co., LTD is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 85248-0017-01 · Jiangxi 85248-0019-01 · Jiangxi →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.